These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16683307)

  • 41. Barrett's esophagus: a pre-cancerous condition approach to diagnosis and management.
    Choueiri NE; Prather CM
    Mo Med; 2009; 106(5):339-42. PubMed ID: 19902713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Any role for endoscopy screening or surveillance for esophageal adenocarcinoma among persons with GERD?
    Lagergren J
    Gastrointest Endosc; 2008 Nov; 68(5):856-8. PubMed ID: 18984099
    [No Abstract]   [Full Text] [Related]  

  • 43. Barrett's esophagus (BE) and carcinoma in the esophageal stump (ES) after esophagectomy with gastric pull-up in achalasia patients: a study based on 10 years follow-up.
    da Rocha JR; Ribeiro U; Sallum RA; Szachnowicz S; Cecconello I
    Ann Surg Oncol; 2008 Oct; 15(10):2903-9. PubMed ID: 18618179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adiposity and columnar-lined esophagus.
    Lenglinger J; Eisler M; Riegler FM
    Am J Gastroenterol; 2008 May; 103(5):1316-7. PubMed ID: 18477363
    [No Abstract]   [Full Text] [Related]  

  • 45. Medical treatment of Barrett's esophagus: can it prevent cancer?
    Sampliner RE
    Surg Oncol Clin N Am; 2009 Jul; 18(3):503-8. PubMed ID: 19500739
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Complications of gastroesophageal reflux].
    Evrard S
    Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S221-8. PubMed ID: 10078453
    [No Abstract]   [Full Text] [Related]  

  • 47. Should patients with pH-documented laryngopharyngeal reflux routinely undergo oesophagogastroduodenoscopy? A retrospective analysis.
    Reichel O; Issing WJ
    J Laryngol Otol; 2007 Dec; 121(12):1165-9. PubMed ID: 17931449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High risk of malignancy in familial Barrett's esophagus: presentation of one family.
    Munitiz V; Parrilla P; Ortiz A; Martinez-de-Haro LF; Yelamos J; Molina J
    J Clin Gastroenterol; 2008 Aug; 42(7):806-9. PubMed ID: 18385604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Strategies for monitoring patients with Barrett's esophagus--pro].
    Rabenstein T; Ell C
    Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1768. PubMed ID: 17713887
    [No Abstract]   [Full Text] [Related]  

  • 50. Infections of the esophagus and the stomach.
    Quiding-Järbrink M; Bove M; Dahlén G
    Periodontol 2000; 2009 Feb; 49():166-78. PubMed ID: 19152533
    [No Abstract]   [Full Text] [Related]  

  • 51. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.
    Lassen A; Hallas J; de Muckadell OB
    Am J Gastroenterol; 2006 Jun; 101(6):1193-9. PubMed ID: 16771936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Gastroesophageal reflux disease--diagnosis and management].
    Wojtuń S; Gil J; Jałocha Ł; Błaszak A; Wojtkowiak M
    Pol Merkur Lekarski; 2009 May; 26(155):512-6. PubMed ID: 19606713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reflux disease and Barrett's esophagus.
    Louis H
    Endoscopy; 2007 Nov; 39(11):969-73. PubMed ID: 17926239
    [No Abstract]   [Full Text] [Related]  

  • 54. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction.
    Chak A; Ochs-Balcom H; Falk G; Grady WM; Kinnard M; Willis JE; Elston R; Eng C
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1668-73. PubMed ID: 16985029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastroesophageal reflux disease and Barrett's esophagus.
    Anand O; Wani S; Sharma P
    Endoscopy; 2008 Feb; 40(2):126-30. PubMed ID: 18058620
    [No Abstract]   [Full Text] [Related]  

  • 56. Strong activation of PAR-2 receptors: a common trigger for the development of gastrointestinal adenocarcinomas?
    Olbe L
    Scand J Gastroenterol; 2007 Sep; 42(9):1133-7. PubMed ID: 17710682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
    Katz PO
    Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Esophageal capsule endoscopy for Barrett's esophagus screening: a hard pill to swallow?
    Hur C
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):307-9. PubMed ID: 17257904
    [No Abstract]   [Full Text] [Related]  

  • 59. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma.
    Gilbert S; Jobe BA
    Surg Oncol Clin N Am; 2009 Jul; 18(3):523-31. PubMed ID: 19500741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups.
    Dickman R; Bautista JM; Wong WM; Bhatt R; Beeler JN; Malagon I; Risner-Adler S; Lam KF; Fass R
    Am J Gastroenterol; 2006 Nov; 101(11):2463-9. PubMed ID: 17090277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.